Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia

Clinical trial NCT02770820 · TERMINATED

Trial details

NCT number: NCT02770820
Sponsor: Fred Hutchinson Cancer Center
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia EBV-Positive Neoplastic Cells Present HLA-A*0201 Positive Cells Present Blasts Under 5 Percent of Bone Marrow Nucleated Cells Elevated WT1

Start date: 2017-11-06
Primary completion: 2020-06-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.